Medgenics Inc. (MDGN: Quote) posted first-quarter net loss of $2.71 million or $0.28 per share, wider than $0.34 million or $0.06 per share in the previous year period.
General and administrative expense for the first quarter increased to $1.36 million from $0.78 million in the comparable quarter last year, primarily due to higher legal and professional services fees and to increased activities in the U.S. as part of forthcoming clinical trials.
Click here to receive FREE breaking news email alerts for Medgenics and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org